Investment Summary

Exits SemBioSys Genetics

On December 6, 2004, invested in consumer products company SemBioSys Genetics from Bay City Capital

Investment Highlights
  • This is transaction in the Consumer Products sector.
  • This is transaction in Canada.
  • This is transaction in Alberta.

Investment Summary

Date 2004-12-06
Target SemBioSys Genetics
Sector Consumer Products
Sellers(s) Bay City Capital
Deal Type IPO

Target

SemBioSys Genetics

Calgary, Alberta, Canada
website
SemBioSys Genetics, Inc. is a developer of high value proteins and oil body based products for personal care, nutrition and pharmaceutical industries using its proprietary oil body/oleosin technology.

Search 177,960 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor

website


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.


DEAL STATS #
Overall 15 of 62
Sector (Consumer Products) 1 of 2
Type (IPO) 9 of 23
State (Alberta) 1 of 1
Country (Canada) 1 of 1
Year (2004) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-10-20 VNUS Medical Technologies

San Jose, California, United States

VNUS Medical Technologies, Inc. is a provider of medical devices for the minimally invasive treatment of venous reflux.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-12-17 Epoch Biosciences

Bothell, Washington, United States

Epoch Biosciences, Inc. is a biotech company focused on development and commercialization of proprietary nucleic acid chemistries for research and diagnostic applications.

Sell -